Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03191604 · ClinicalTrials.gov registry record
Impact of NBI on Patients Undergoing Endoscopic Eradication Therapy
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 46
- Enrollment target
NCT03191604: Completed study, sponsored by Northwestern University.
NCT03191604 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03191604 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
This study tests the impact of narrow band imaging (NBI) on endoscopists' accurate detection of visible lesions and dysplasia in patients with Barrett's esophagus, as well as the effect of NBI on the choice of primary treatment modality among endoscopists performing endoscopic eradication therapy (EET).
Primary Outcome
Percentage of cases in which use of NBI altered decision-making in regards to initial treatment modality for patients undergoing EET.
Interventions
- OTHER Video intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2019-05-10 |
What the finished NCT03191604 record still lists
NCT03191604 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Video intervention is the first listed.
NCT03191604 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03191604 about?
NCT03191604 is a clinical study titled "Impact of NBI on Patients Undergoing Endoscopic Eradication Therapy". This study tests the impact of narrow band imaging (NBI) on endoscopists' accurate detection of visible lesions and dysplasia in patients with Barrett's esophagus, as well as the effect of NBI on the choice of primary treatment modality among endoscopists performing endoscopic eradication therapy (E...
What is the current status of trial NCT03191604?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2017-11-01. Estimated completion is 2019-05-10.
What interventions are being tested in trial NCT03191604?
The interventions under investigation include: Video intervention (OTHER).
Who is sponsoring clinical trial NCT03191604?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI